The Dark Report and Siemens Introduce the World's First Integrated Molecular Summit
January 28 2008 - 8:00AM
PR Newswire (US)
Thomas Miller, CEO Workflow and Solutions Division, Siemens
Healthcare, to Serve as Event Keynote Speaker PHILADELPHIA, Jan. 28
/PRNewswire-FirstCall/ -- Recent advances in genetic knowledge are
transforming molecular imaging, molecular diagnostics and
informatics to create stunningly precise diagnostic tools capable
of assessing and treating a growing number of critical diseases.
These new diagnostic tools provide physicians with an understanding
of individual patient or disease differences at the molecular or
genetic level, enabling them to leverage predictive diagnosis and
tailor effective treatment to the individual. (Logo:
http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ) To
address this new frontier in healthcare, Thomas Miller, CEO of
Siemens Healthcare's Workflow and Solutions Division, will serve as
a keynote speaker at the first international Molecular Summit on
the integration of in vivo and in vitro diagnostics on February
5-6, 2008, at the Sheraton Society Hill Hotel in Philadelphia.
Miller will discuss Siemens' vision for a new era in medicine, one
enabled through integration of molecular imaging, molecular
diagnostics and informatics, specifically how the integration of
these disciplines will lead to predictive diagnosis and
individualized treatment - true personalized medicine, which will
result in improved patient outcomes. Additionally, he will speak
about Siemens' business strategy for becoming the world's first and
pre-eminent leader in in vivo and in vitro diagnostics About the
Summit The Dark Report and Siemens have assembled an international
faculty of experts and early adopters of integrated diagnostic care
pathways within radiology and pathology to address the first
international Molecular Summit on the integration of in vivo and in
vitro diagnostics. Conference attendees will have a choice of
attending more than 26 educational sessions to learn how innovators
are advancing clinical care and enhancing their financial strength
by incorporating the latest molecular imaging techniques in tandem
with emerging molecular diagnostics. Industry pioneers will speak
about evolving changes in R&D, the discovery of new medicines,
effective policies to translate these discoveries into better
outcomes for patients, resulting treatments that improve
healthcare, and new business strategies to advance the field of
personalized medicine. Continuing Education Units (CEU's) are
provided by the American Association of Clinical Chemistry (AACC).
"Healthcare is evolving, entering a new era, one created through
the marriage of in vivo and in vitro diagnostics, arming clinicians
with the tools that enable early intervention and treatment in a
way that improves clinical efficiencies, effectiveness and
outcomes," said Thomas Miller, CEO, Workflow and Solutions
Division, Siemens Healthcare. "We are ushering in the era of
personalized medicine, moving the practice of medicine from the
disease- centric to the knowledge-driven, patient-centric approach.
For all of us who care passionately about this -- pathologists,
radiologists and healthcare IT executives -- the Summit will
deliver the latest information defining the next generation of
integrated diagnostic and clinical services." The Molecular Summit
will feature case studies involving the delivery of molecular
imaging and molecular diagnostics services, particularly where
collaboration is occurring between radiology, pathology, and
informatics to integrate molecular imaging with relevant molecular
diagnostics services. "Alert physicians involved in imaging and
molecular diagnostics know these technology advances are already
breaking down traditional specialty silos," said Robert L. Michel,
editor, The Dark Report. "The Molecular Summit brings together
early adopters who will share their practical experiences and
discuss emerging opportunities." Case studies and presentations
will illustrate new technology, effective use of informatics to
support molecular imaging and molecular diagnostics, and new
developments in the way clinicians use these technologies. The
Summit will also feature highlights of molecular diagnostics
implemented in clinical laboratories, imaging centers, pathology
groups, radiology groups, hospitals, and health systems. Speakers
will deliver strategic presentations on how healthcare and
diagnostic medicine will utilize molecular technologies in imaging,
diagnostics and informatics in the future, and industry experts
will conduct strategic assessments of the growing field of
molecular medicine, identify emerging trends, and discuss how
government and private payers are likely to respond with new
coverage guidelines and reimbursement levels. More information
about the event can be found at http://www.molecular-summit.com/.
About Siemens Healthcare Siemens Healthcare is one of the world's
largest suppliers to the healthcare industry. The company is a
renowned medical solutions provider with core competence and
innovative strength in diagnostic and therapeutic technologies as
well as in knowledge engineering, including information technology
and system integration. With its laboratory diagnostics
acquisitions, Siemens Healthcare will be the first fully integrated
diagnostics company, bringing together imaging and lab diagnostics,
therapy, and healthcare information technology solutions,
supplemented by consulting and support services. Siemens Healthcare
delivers solutions across the entire continuum of care -- from
prevention and early detection, to diagnosis, therapy and care. The
company employs more than 49,000 people worldwide and operates in
130 countries. In the fiscal year 2007 (Sept. 30), Siemens
Healthcare reported sales of euro 9.85, orders of euro 10.27
billion, and group profit of euro 1.32 billion. Further information
can be found by visiting http://www.siemens.com/healthcare
http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO
http://photoarchive.ap.org/ DATASOURCE: Siemens CONTACT: Amanda
Naiman of Siemens, +1-610-448-4531, Web site:
http://www.siemens.com/healthcare http://www.molecular-summit.com/
Copyright